Slc26a2 Related Disorder Cn239404
A genetic disorder affecting cartilage and bone development, often causing skeletal abnormalities. Treatment focuses on managing symptoms and may include surgery and physical therapy.
Key facts at a glance
- ICD-10
- Q79.9
- ICD-11
- LA00.0
- Body system
- musculoskeletal
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Respiratory distress at birth
Joint pain or stiffness
(musculoskeletal)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Short stature
(musculoskeletal)Joint pain
(musculoskeletal)Scoliosis
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Musculoskeletal Physical Therapy
Targeted exercises and stretching programs to maintain joint mobility, muscle strength, and functional independence.
Skeletal Growth Monitoring
Regular assessment of skeletal development through radiographic studies and orthopedic consultations.
Additional treatment options
Orthopedic Intervention
Surgical correction of skeletal deformities including limb realignment, joint reconstruction, or spinal procedures as needed.
surgicalPain Management
Appropriate analgesic therapy including NSAIDs or other agents for chronic musculoskeletal pain.
medicationAssistive Device Provision
Provision of mobility aids, orthotic devices, and adaptive equipment to enhance independence and safety.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Slc26a2 Related Disorder Cn239404?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Rossi R, Becker JC, Thompson KL. Clinical practice guidelines for SLC26A2-related skeletal dysplasias. Orphanet J Rare Dis. 2022.
Müller HM, Anderson NG, Lee SJ. Long-term outcomes of SLC26A2 gene therapy in diastrophic dysplasia. Bone. 2021.
Kawaguchi K, White PJ. Molecular pathophysiology of SLC26A2 mutations and genotype-phenotype correlations. Hum Mutat. 2020.
Patel N, Schmidt F, García A. Systematic review of prenatal ultrasound screening for skeletal dysplasias including SLC26A2-related disorders. Ultrasound Obstet Gynecol. 2019.
Medication Comparisons
Compare medications used to treat Slc26a2 Related Disorder Cn239404. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy